Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News  >  Business Leaders  >  Business Leaders Biography

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
HomeAll newsMost read newsBusiness Leaders Biography
Portrait de Ulf Mark Schneider
Age : 52
Public asset : 197,068 USD
Country of residence : Unknown
Linked companies : Nestle SA

Dr. Ulf Mark Schneider is a Chief Executive Officer & Director at Nestlé SA, a Chairman-Supervisory Board at EUFETS AG, a Chairman-Supervisory Board at Fresenius Medical Care Groupe France SAS and a Chairman-Supervisory Board at Fresenius Medical Care Management AG.

He is on the Board of Directors at Société des Produits Nestlé SA, Nestlé SA, DuPont Safety Resources, FPS Beteiligungs AG, NPBI International BV, FHC Holdings Ltd., Fresenius Kabi USA, Inc., The Consumer Goods Forum, Fresenius Hemocare Netherlands B.V. and Fresenius Kabi España SA. Dr. Schneider was previously employed as an Independent Director by E.I. du Pont de Nemours & Co., a Chief Financial Officer by Fresenius Medical Care AG & Co. KGaA, a Chairman-Management Board by Fresenius SE & Co. KGaA, a Chairman-Supervisory Board by Fresenius Kabi AG, a Member-Supervisory Board by Fresenius Kabi Austria GmbH, a Chairman-Management Board by Fresenius Management SE, a Group Finance Director by Gehe UK Plc, and a Chairman-Supervisory Board by HELIOS Kliniken GmbH.

He also served on the board at APP Pharmaceuticals, Inc. and Fresenius Kabi Pharmaceuticals Holding, Inc. (United States).

He received his MBA from Harvard Business School and a doctorate degree from the University of St. Gallen.

Current positions of Ulf Mark Schneider 
NameTitle Since
Nestle SA
(Food Processing)
Chief Executive Officer & Director 2016
EUFETS AG Chairman-Supervisory Board -
Cereal Partners Worldwide SA Co-Chairman -
Fresenius Medical Care Groupe France SAS Chairman-Supervisory Board -
Fresenius Medical Care Management AG Chairman-Supervisory Board -
NPBI International BV Member-Supervisory Board 2004
DuPont Safety Resources Director 2014
Fresenius Hemocare Netherlands B.V. Member-Supervisory Board -
Fresenius Kabi España SA Member-Supervisory Board -
FHC Holdings Ltd. Director -
The Consumer Goods Forum Director -
Société des Produits Nestlé SA Director 2017
FPS Beteiligungs AG Member-Supervisory Board 2012
Fresenius Kabi USA, Inc. Director -

Ulf Mark Schneider : Personal Network 
NameLinked companies
Stephan Sturm Fresenius Kabi España SA
FHC Holdings Ltd.
Fresenius Medical Care Management AG
Fresenius Hemocare Netherlands B.V.
FPS Beteiligungs AG
Laurent Freixe Nestle SA
Cereal Partners Worldwide SA
The Consumer Goods Forum
Société des Produits Nestlé SA
Rainer Baule FHC Holdings Ltd.
Fresenius Kabi España SA
NPBI International BV
Fresenius Hemocare Netherlands B.V.
Paul Bulcke Nestle SA
Cereal Partners Worldwide SA
The Consumer Goods Forum
Mats Christer Henriksson FHC Holdings Ltd.
Fresenius Kabi USA, Inc.
Fresenius Kabi España SA
Wan Ling Martello Nestle SA
Cereal Partners Worldwide SA
Chris Johnson Nestle SA
Cereal Partners Worldwide SA
Patrice Bula Nestle SA
Cereal Partners Worldwide SA
Peter Brabeck-Letmathe Nestle SA
Ursula Burns Nestle SA

Biography of Ulf Mark Schneider 
Ulf Mark Schneider (born 1965) is the current CEO of Fresenius, a $26 billion global health care group.

Life and career
Schneider was born and raised in Germany and became a U.S. citizen in 2003. He holds a doctorate in economics from the University of St. Gallen, Switzerland, and an MBA from Harvard Business School. Schneider joined Fresenius in November 2001 and served as Chief Financial Officer of Fresenius Medical Care before assuming his current position in May, 2003. Previously, he was Group Finance Director for Gehe UK plc., a pharmaceutical wholesale and retail distributor, in Coventry, England. Schneider held several senior executive positions starting in 1989 with Gehe’s majority shareholder, Franz Haniel & Cie. GmbH, a diversified German industrial company. Under Schneider's leadership, Fresenius' revenue has almost tripled, the number of employees has more than tripled and net income has increased approximately eightfold. Since Schneider became CEO, Fresenius has also carried out a number of major strategic acquisitions: the private hospital chain HELIOS Kliniken in 2005; U.S. dialysis provider Renal Care Group, in 2006; U.S. pharmaceutical company APP Pharmaceuticals, in 2008; Liberty Dialysis, another major dialysis provider in the United States, in 2011; and, in 2014, the purchase of 41 hospitals from Rhön-Klinikum, through which HELIOS became the largest private hospital operator in Germany.

The management challenges of global growth and future strategies in the health care and pharmaceutical industries are of particular interest to Schneider.

Schneider chairs the European Advisory Board of Harvard Business School, and serves on the Board of Directors of the American chemical company DuPont.

Source @ Wikipedia

Most Read News 
03/16WARREN BUFFETT : Berkshire says median employee makes over half Buffett's pay
03/22MARK ZUCKERBERG : Zuckerberg apologises for Facebook mistakes with user data, vows curbs
03/20STEVE WYNN : Top Company News of the Day
03/22ELON MUSK : Tesla shareholders approve CEO Musk's $2.6 billion compensation plan
03:34aRUPERT MURDOCH : Four senior MPs urge regulator to block Murdoch-Sky deal
03/16HOCK TAN : Deal Maker Without a Deal -- WSJ
03/19MARK ZUCKERBERG : Democratic senator asks Zuckerberg about Facebook data
03/16STEVE WYNN : Top Company News of the Day
03/19PAUL JACOBS : Qualcomm CEO Steve Mollenkopf Faces Fights on Many Fronts
05:20aSTEVE WYNN : Steve Wynn sells stake in company he founded, Macau casino Galaxy buys in
More news

© 2018 People and Ownership :   
Ulf Mark Schneider : Connections 
Fresenius Kabi Groupe France
Nestlé Entreprises SAS
Dairy Partners Américas Brasil Ltda.
Nestlé Suisse SA
Société des Produits Nestlé SA
Fresenius Kabi (Singapore) Pte Ltd.

Latest news about Ulf Mark Schneider 
2017Nestlé Exploring Sale of Its U.S. Confectionery Business -- 2nd Update
2017Fresenius picks up M&A pace with Akorn, Merck KGaA deals
2017Unilever Joins Race to Shed Food Businesses -- WSJ
2017Unilever to Restructure, Raise Returns in Wake of Kraft Bid -- 6th Update
2017Nestle Needs Three-Year 'Time Out' From Organic Growth Target -- CEO
2017Nestlé Misses Growth Target for Fourth Straight Year -- Update
2017Nestlé Reports Drop in Sales, Profit -- Update
More news

Popular Business Leaders 
William Ackman Frank Appel Bernard Arnault Jeff Bezos Lloyd Blankfein Michael Bloomberg Vincent Bolloré Warren Buffett Jean-pierre Clamadieu Gary Cohn Tim Cook Richard Cousins Elmar Degenhart Michael Dell Jamie Dimon Sergio Ermotti Bill Gates Carlos Ghosn David Henry Heinrich Hiesinger Carl Icahn Robert Iger Paul Jacobs Ingvar Kamprad Dara Khosrowshahi Isabelle Kocher Jack Ma Gérard Mestrallet Lakshmi Mittal Rupert Murdoch Elon Musk Peter Nicholas Michael O'leary Nelson Peltz Robert Peugeot Alexandre Ricard Stéphane Richard Wilbur Ross Charles Schwab George Soros Martin Sorrell Rupert Stadler Hock Tan Peter Thiel John Williamson Thomas Wilson Elaine Wynn Dieter Zetsche Mark Zuckerberg
A-Z Business Leaders